Medlab Clinical Ltd (ASX:MDC), an Australian biotech using delivery platforms to enhance medicines is pleased to announce the execution of a Master Services Agreement with WEP Clinical Ltd for the exclusive development and delivery of Named Patient Programmes
Candy Club Holdings Limited (ASX:CLB) has successfully completed a A$10.7 million institutional placement, issuing 48.6 million of fully paid ordinary shares at $0.22 per share.
Candy Club Holdings Limited (ASX:CLB) has announced its results for the three months ending 31 December 2020 ("4Q FY2020") today.
Candy Club Holdings Limited (ASX:CLB) has successfully completed a $5 million private placement from institutional and sophisticated investors.
AusCann Group Holdings Ltd (ASX:AC8), an Australian based pharmaceutical company focused on the development, production and distribution of cannabinoid-based medicines within Australia and internationally, is pleased to announce that it has entered into a scheme implementation deed (SID) with CannPal Animal Therapeutics Limited.
Cann Global continued to drive sales throughout the quarter resulting in cash receipts from customers of $333k up 54.6% on the prior corresponding period, but lower than the prior quarter due to shipping delays and therefore delayed payment on contracted sales.
Cann Global Limited (ASX:CGB) is pleased to confirm that the 1 for 4 renounceable entitlement offer announced on 3 July 2020 (Entitlement Offer), closed on Thursday 23 July 2020.
